Ra. Rabini et al., NA-ATPASE OF HUMAN PLACENTA DURING GESTATIONAL HYPERTENSION - A BIOCHEMICAL-BIOPHYSICAL STUDY(,K+), Clinical science, 91(6), 1996, pp. 719-723
1. Na+,K+-ATPase is the membrane enzyme catalysing the active transpor
t of Na+ and K+ across the plasma membrane of animal cells, A reduced
activity of Na+,K+-ATPase has been described in gestational hypertensi
on in a variety of cell types, in agreement with the hypothesis that g
estational hypertension can induce membrane transport modifications si
milar to those reported for essential hypertension, The causes of the
reduced Na+,K+-ATPase activity are still debated. 2. The aim of the pr
esent work was to investigate the molecular mechanism of the reduced e
nzymic activity in gestational hypertension using as a model Na+,K+-AT
Pase purified from human placenta. Na+,K+-ATPase obtained from term pl
acentas of eight healthy pregnant women and eight age-matched women wi
th gestational hypertension was purified as previously described. 3. W
e observed in gestational hypertension: (i) a significant increase in
the activation energies above transition temperature; (ii) a significa
nt decrease in the fluorescence polarization of (4-trimethylaminopheny
l)-6-phenyl-1,3,5-hexatriene (i,e, increased fluidity) and an increase
in the mean lifetime (modified hydrophobicity); (iii) a lower K-q, su
ggesting an enzymic structural modification; and (iv) an increased mea
n lifetime and rotational relaxation time of pyrene isothiocyanate, in
dicating a modified ATP binding site.